Zimbabwe has turned down a significant American healthcare agreement valued at $367m (£272m) spanning five years due to the United States' request for sensitive biological samples.
The decision became public following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesman later clarified that the United States was seeking health data for scientific study and commercial purposes while was not willing to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to secure a agreement agreeable to both sides so the nation's vital HIV programme can proceed.
Wider Background
This development comes after a similar situation in neighbouring Kenya, where a high court blocked a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed assistance for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
According to reports, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our population if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures previously established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This system is intended to guarantee that when a country contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that honours the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks should continue considering a large portion of the nation's HIV programmes depended on external financing.
"If technical issues exist, including those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it said.
The situation highlights the continuing debate between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.